Skip to main content

25.04.2024 | Original Paper

Empirical Development of a Behavioral Intervention for African American/Black and Latino Persons with Unsuppressed HIV Viral Load Levels: An Application of the Multiphase Optimization Strategy (MOST) Using Cost-Effectiveness as an Optimization Objective

verfasst von: Jonathan Feelemyer, R Scott Braithwaite, Qinlian Zhou, Charles M. Cleland, Prima Manandhar-Sasaki, Leo Wilton, Amanda Ritchie, Linda M. Collins, Marya V. Gwadz

Erschienen in: AIDS and Behavior

Einloggen, um Zugang zu erhalten

Abstract

We used results from an optimization randomized controlled trial which tested five behavioral intervention components to support HIV antiretroviral adherence/HIV viral suppression, grounded in the multiphase optimization strategy and using a fractional factorial design to identify intervention components with cost-effectiveness sufficiently favorable for scalability. Results were incorporated into a validated HIV computer simulation to simulate longer-term effects of combinations of components on health and costs. We simulated the 32 corresponding long-term trajectories for viral load suppression, health related quality of life (HRQoL), and costs. The components were designed to be culturally and structurally salient. They were: motivational interviewing counseling sessions (MI), pre-adherence skill building (SB), peer mentorship (PM), focused support groups (SG), and patient navigation (short version [NS], long version [NL]. All participants also received health education on HIV treatment. We examined four scenarios: one-time intervention with and without discounting and continuous interventions with and without discounting. In all four scenarios, interventions that comprise or include SB and NL (and including health education) were cost effective (< $100,000/quality-adjusted life year). Further, with consideration of HRQoL impact, maximal intervention became cost-effective enough to be scalable. Thus, a fractional factorial experiment coupled with cost-effectiveness analysis is a promising approach to optimize multi-component interventions for scalability. The present study can guide service planning efforts for HIV care settings and health departments.
Literatur
1.
Zurück zum Zitat Centers for Disease Control & Prevention. Viral suppression. HIV in the United States and dependent areas. Atlanta GA; 2022. Centers for Disease Control & Prevention. Viral suppression. HIV in the United States and dependent areas. Atlanta GA; 2022.
2.
Zurück zum Zitat Adeyemi OM, Livak B, McLoyd P, Smith KY, French AL. Racial/ethnic disparities in engagement in care and viral suppression in a large urban HIV clinic. Clin Infect Dis. 2013;56(10):1512–4.PubMedPubMedCentralCrossRef Adeyemi OM, Livak B, McLoyd P, Smith KY, French AL. Racial/ethnic disparities in engagement in care and viral suppression in a large urban HIV clinic. Clin Infect Dis. 2013;56(10):1512–4.PubMedPubMedCentralCrossRef
3.
Zurück zum Zitat Crepaz N, Dong X, Hess KL, Bosh K. Racial and ethnic disparities in sustained viral suppression and transmission risk potential among persons aged 13–29 years living with diagnosed HIV infection, United States, 2016. J Acquir Immune Defic Syndr. 2020;83(4):334.PubMedPubMedCentralCrossRef Crepaz N, Dong X, Hess KL, Bosh K. Racial and ethnic disparities in sustained viral suppression and transmission risk potential among persons aged 13–29 years living with diagnosed HIV infection, United States, 2016. J Acquir Immune Defic Syndr. 2020;83(4):334.PubMedPubMedCentralCrossRef
4.
Zurück zum Zitat Crepaz N, Dong X, Wang X, Hernandez AL, Hall HI. Racial and ethnic disparities in sustained viral suppression and transmission risk potential among persons receiving HIV care—United States, 2014. Morb Mortal Wkly Rep. 2018;67(4):113.CrossRef Crepaz N, Dong X, Wang X, Hernandez AL, Hall HI. Racial and ethnic disparities in sustained viral suppression and transmission risk potential among persons receiving HIV care—United States, 2014. Morb Mortal Wkly Rep. 2018;67(4):113.CrossRef
5.
6.
Zurück zum Zitat Sahker E, Toussaint MN, Ramirez M, Ali SR, Arndt S. Evaluating racial disparity in referral source and successful completion of substance abuse treatment. Addict Behav. 2015;48:25–9.PubMedCrossRef Sahker E, Toussaint MN, Ramirez M, Ali SR, Arndt S. Evaluating racial disparity in referral source and successful completion of substance abuse treatment. Addict Behav. 2015;48:25–9.PubMedCrossRef
7.
Zurück zum Zitat Anglin DM, Alberti PM, Link BG, Phelan JC. Racial differences in beliefs about the effectiveness and necessity of mental health treatment. Am J Community Psychol. 2008;42:17–24.PubMedPubMedCentralCrossRef Anglin DM, Alberti PM, Link BG, Phelan JC. Racial differences in beliefs about the effectiveness and necessity of mental health treatment. Am J Community Psychol. 2008;42:17–24.PubMedPubMedCentralCrossRef
8.
Zurück zum Zitat Bradley H, Rosenberg ES, Holtgrave DR. Data-Driven goals for curbing the U.S. HIV Epidemic by 2030. AIDS Behav. 2019;23(3):557–63.PubMedCrossRef Bradley H, Rosenberg ES, Holtgrave DR. Data-Driven goals for curbing the U.S. HIV Epidemic by 2030. AIDS Behav. 2019;23(3):557–63.PubMedCrossRef
9.
Zurück zum Zitat UNAIDS. Understanding fast-track: Accelerating action to end the AIDS epidemic by 2030. UNAIDS Geneva 2015. UNAIDS. Understanding fast-track: Accelerating action to end the AIDS epidemic by 2030. UNAIDS Geneva 2015.
10.
Zurück zum Zitat UNAIDS. Understanding Fast-Track: Accelarating Action to End the AIDS Epidemic by 2030. In, Edited. by HIV/AIDS JUNPo. Geneva Switzerland; 2022. UNAIDS. Understanding Fast-Track: Accelarating Action to End the AIDS Epidemic by 2030. In, Edited. by HIV/AIDS JUNPo. Geneva Switzerland; 2022.
12.
Zurück zum Zitat Protopopescu C, Marcellin F, Spire B, Préau M, Verdon R, Peyramond D, et al. Health-related quality of life in HIV-1-infected patients on HAART: a five-years longitudinal analysis accounting for dropout in the APROCO-COPILOTE cohort (ANRS CO-8). Qual Life Res. 2007;16:577–91.PubMedCrossRef Protopopescu C, Marcellin F, Spire B, Préau M, Verdon R, Peyramond D, et al. Health-related quality of life in HIV-1-infected patients on HAART: a five-years longitudinal analysis accounting for dropout in the APROCO-COPILOTE cohort (ANRS CO-8). Qual Life Res. 2007;16:577–91.PubMedCrossRef
13.
Zurück zum Zitat Ruiz Perez I, Rodriguez Bano J, Lopez Ruz MA, Del Arco Jimenez A, Causse Prados M, Pasquau Liano J, et al. Health-related quality of life of patients with HIV: impact of sociodemographic, clinical and psychosocial factors. Qual Life Res. 2005;14(5):1301–10.PubMedCrossRef Ruiz Perez I, Rodriguez Bano J, Lopez Ruz MA, Del Arco Jimenez A, Causse Prados M, Pasquau Liano J, et al. Health-related quality of life of patients with HIV: impact of sociodemographic, clinical and psychosocial factors. Qual Life Res. 2005;14(5):1301–10.PubMedCrossRef
14.
Zurück zum Zitat Andersson GZ, Reinius M, Eriksson LE, Svedhem V, Esfahani FM, Deuba K, et al. Stigma reduction interventions in people living with HIV to improve health-related quality of life. Lancet HIV. 2020;7(2):e129–40.PubMedCrossRef Andersson GZ, Reinius M, Eriksson LE, Svedhem V, Esfahani FM, Deuba K, et al. Stigma reduction interventions in people living with HIV to improve health-related quality of life. Lancet HIV. 2020;7(2):e129–40.PubMedCrossRef
15.
Zurück zum Zitat Call S, Klapow J, Stewart K, Westfall A, Mallinger A, DeMasi R, et al. Health-related quality of life and virologic outcomes in an HIV clinic. Qual Life Res. 2000;9:977–85.PubMedCrossRef Call S, Klapow J, Stewart K, Westfall A, Mallinger A, DeMasi R, et al. Health-related quality of life and virologic outcomes in an HIV clinic. Qual Life Res. 2000;9:977–85.PubMedCrossRef
16.
Zurück zum Zitat Hughes J, Jelsma J, Maclean E, Darder M, Tinise X. The health-related quality of life of people living with HIV/AIDS. Disabil Rehabil. 2004;26(6):371–6.PubMedCrossRef Hughes J, Jelsma J, Maclean E, Darder M, Tinise X. The health-related quality of life of people living with HIV/AIDS. Disabil Rehabil. 2004;26(6):371–6.PubMedCrossRef
17.
Zurück zum Zitat Parcesepe AM, Nash D, Tymejczyk O, Reidy W, Kulkarni SG, Elul B, Gender. HIV-Related Stigma, and Health-related quality of life among adults enrolling in HIV Care in Tanzania. AIDS Behav. 2020;24(1):142–50.PubMedCrossRef Parcesepe AM, Nash D, Tymejczyk O, Reidy W, Kulkarni SG, Elul B, Gender. HIV-Related Stigma, and Health-related quality of life among adults enrolling in HIV Care in Tanzania. AIDS Behav. 2020;24(1):142–50.PubMedCrossRef
18.
Zurück zum Zitat Nanni MG, Caruso R, Mitchell AJ, Meggiolaro E, Grassi L. Depression in HIV infected patients: a review. Curr Psychiatry Rep. 2014;17(1):530.CrossRef Nanni MG, Caruso R, Mitchell AJ, Meggiolaro E, Grassi L. Depression in HIV infected patients: a review. Curr Psychiatry Rep. 2014;17(1):530.CrossRef
19.
Zurück zum Zitat Zinkernagel C, Taffé P, Rickenbach M, Amiet R, Ledergerber B, Volkart A-C, et al. Importance of mental health assessment in HIV-infected outpatients. JAIDS J Acquir Immune Defic Syndr. 2001;28(3):240–9.PubMedCrossRef Zinkernagel C, Taffé P, Rickenbach M, Amiet R, Ledergerber B, Volkart A-C, et al. Importance of mental health assessment in HIV-infected outpatients. JAIDS J Acquir Immune Defic Syndr. 2001;28(3):240–9.PubMedCrossRef
20.
Zurück zum Zitat Regan T, Gette J, McAfee N, Parker J. Substance use disparities by age, race, sex, and sexual orientation among persons living with HIV in the Southern U.S. Int J STD AIDS. 2023;34(7):476–83.PubMedCrossRef Regan T, Gette J, McAfee N, Parker J. Substance use disparities by age, race, sex, and sexual orientation among persons living with HIV in the Southern U.S. Int J STD AIDS. 2023;34(7):476–83.PubMedCrossRef
21.
Zurück zum Zitat Laudet AB. The case for considering quality of life in addiction research and clinical practice. Addict Sci Clin Pract 2011; 6(1). Laudet AB. The case for considering quality of life in addiction research and clinical practice. Addict Sci Clin Pract 2011; 6(1).
22.
Zurück zum Zitat Korthuis PT, Zephyrin LC, Fleishman JA, Saha S, Josephs JS, McGrath MM, et al. Health-related quality of life in HIV-infected patients: the role of substance use. AIDS Patient Care STDS. 2008;22(11):859–67.PubMedPubMedCentralCrossRef Korthuis PT, Zephyrin LC, Fleishman JA, Saha S, Josephs JS, McGrath MM, et al. Health-related quality of life in HIV-infected patients: the role of substance use. AIDS Patient Care STDS. 2008;22(11):859–67.PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat e Silva AC, Reis RK, Nogueira JA, Gir E. Quality of life, clinical characteristics and treatment adherence of people living with HIV/AIDS. Rev Lat Am Enfermagem. 2014;22(6):994–1000.PubMedCentralCrossRef e Silva AC, Reis RK, Nogueira JA, Gir E. Quality of life, clinical characteristics and treatment adherence of people living with HIV/AIDS. Rev Lat Am Enfermagem. 2014;22(6):994–1000.PubMedCentralCrossRef
24.
Zurück zum Zitat Penedo FJ, Gonzalez JS, Dahn JR, Antoni M, Malow R, Costa P, et al. Personality, quality of life and HAART adherence among men and women living with HIV/AIDS. J Psychosom Res. 2003;54(3):271–8.PubMedCrossRef Penedo FJ, Gonzalez JS, Dahn JR, Antoni M, Malow R, Costa P, et al. Personality, quality of life and HAART adherence among men and women living with HIV/AIDS. J Psychosom Res. 2003;54(3):271–8.PubMedCrossRef
25.
Zurück zum Zitat Binford MC, Kahana SY, Altice FL. A systematic review of antiretroviral adherence interventions for HIV-infected people who use drugs. Curr HIV/AIDS Rep. 2012;9:287–312.PubMedCrossRef Binford MC, Kahana SY, Altice FL. A systematic review of antiretroviral adherence interventions for HIV-infected people who use drugs. Curr HIV/AIDS Rep. 2012;9:287–312.PubMedCrossRef
26.
Zurück zum Zitat Kanters S, Park JJ, Chan K, Socias ME, Ford N, Forrest JI, et al. Interventions to improve adherence to antiretroviral therapy: a systematic review and network meta-analysis. Lancet HIV. 2017;4(1):e31–40.PubMedCrossRef Kanters S, Park JJ, Chan K, Socias ME, Ford N, Forrest JI, et al. Interventions to improve adherence to antiretroviral therapy: a systematic review and network meta-analysis. Lancet HIV. 2017;4(1):e31–40.PubMedCrossRef
27.
Zurück zum Zitat Whiteley LB, Olsen EM, Haubrick KK, Odoom E, Tarantino N, Brown LK. A review of interventions to enhance HIV medication adherence. Curr HIV/AIDS Rep. 2021;18(5):443–57.PubMedCrossRef Whiteley LB, Olsen EM, Haubrick KK, Odoom E, Tarantino N, Brown LK. A review of interventions to enhance HIV medication adherence. Curr HIV/AIDS Rep. 2021;18(5):443–57.PubMedCrossRef
28.
Zurück zum Zitat Kay ES, Batey DS, Mugavero MJ. The HIV treatment cascade and care continuum: updates, goals, and recommendations for the future. AIDS Res Therapy. 2016;13(1):1–7.CrossRef Kay ES, Batey DS, Mugavero MJ. The HIV treatment cascade and care continuum: updates, goals, and recommendations for the future. AIDS Res Therapy. 2016;13(1):1–7.CrossRef
29.
Zurück zum Zitat Centers for Disease Control & Prevention. Understanding the HIV Care Continuum. In. Edited by CDC. Atlanta GA; 2019. Centers for Disease Control & Prevention. Understanding the HIV Care Continuum. In. Edited by CDC. Atlanta GA; 2019.
30.
Zurück zum Zitat Williams JK, Wyatt GE, Wingood G. The four cs of HIV prevention with African americans: crisis, condoms, culture, and community. Curr HIV/AIDS Rep. 2010;7(4):185–93.PubMedPubMedCentralCrossRef Williams JK, Wyatt GE, Wingood G. The four cs of HIV prevention with African americans: crisis, condoms, culture, and community. Curr HIV/AIDS Rep. 2010;7(4):185–93.PubMedPubMedCentralCrossRef
31.
Zurück zum Zitat Friedrich CM. What’s the program worth? Analyzing optimal investment in HIV prevention programs. Stanford University; 2000. Friedrich CM. What’s the program worth? Analyzing optimal investment in HIV prevention programs. Stanford University; 2000.
32.
Zurück zum Zitat Gwadz MV, Collins LM, Cleland CM, Leonard NR, Wilton L, Gandhi M, et al. Using the multiphase optimization strategy (MOST) to optimize an HIV care continuum intervention for vulnerable populations: a study protocol. BMC Public Health. 2017;17(1):1–20.CrossRef Gwadz MV, Collins LM, Cleland CM, Leonard NR, Wilton L, Gandhi M, et al. Using the multiphase optimization strategy (MOST) to optimize an HIV care continuum intervention for vulnerable populations: a study protocol. BMC Public Health. 2017;17(1):1–20.CrossRef
33.
Zurück zum Zitat Collins LM, Strayhorn JC, Vanness DJ. One view of the next decade of research on behavioral and biobehavioral approaches to cancer prevention and control: intervention optimization. Translational Behav Med. 2021;11(11):1998–2008.CrossRef Collins LM, Strayhorn JC, Vanness DJ. One view of the next decade of research on behavioral and biobehavioral approaches to cancer prevention and control: intervention optimization. Translational Behav Med. 2021;11(11):1998–2008.CrossRef
34.
Zurück zum Zitat Collins LM, Kugler KC. Optimization of behavioral, biobehavioral, and biomedical interventions. Cham: Springer Int Publishing. 2018;10(1007):978–973. Collins LM, Kugler KC. Optimization of behavioral, biobehavioral, and biomedical interventions. Cham: Springer Int Publishing. 2018;10(1007):978–973.
35.
Zurück zum Zitat Cleland CM, Gwadz M, Collins LM, Wilton L, Leonard NR, Ritchie AS, et al. Effects of Behavioral Intervention Components for African American/Black and latino persons living with HIV with non-suppressed viral load levels: results of an optimization trial. AIDS and Behavior; 2023. Cleland CM, Gwadz M, Collins LM, Wilton L, Leonard NR, Ritchie AS, et al. Effects of Behavioral Intervention Components for African American/Black and latino persons living with HIV with non-suppressed viral load levels: results of an optimization trial. AIDS and Behavior; 2023.
36.
Zurück zum Zitat Cluesman SR, Gwadz M, Freeman R, Collins LM, Cleland CM, Wilton L, et al. Exploring behavioral intervention components for African American/Black and latino persons living with HIV with non-suppressed HIV viral load in the United States: a qualitative study. Int J Equity Health. 2023;22(1):1–29.CrossRef Cluesman SR, Gwadz M, Freeman R, Collins LM, Cleland CM, Wilton L, et al. Exploring behavioral intervention components for African American/Black and latino persons living with HIV with non-suppressed HIV viral load in the United States: a qualitative study. Int J Equity Health. 2023;22(1):1–29.CrossRef
37.
Zurück zum Zitat Gwadz M, Cluesman SR, Freeman R, Collins LM, Dorsen C, Hawkins RL, et al. Advancing behavioral interventions for African American/Black and latino persons living with HIV using a new conceptual model that integrates critical race theory, harm reduction, and self-determination theory: a qualitative exploratory study. Int J Equity Health. 2022;21(1):97.PubMedPubMedCentralCrossRef Gwadz M, Cluesman SR, Freeman R, Collins LM, Dorsen C, Hawkins RL, et al. Advancing behavioral interventions for African American/Black and latino persons living with HIV using a new conceptual model that integrates critical race theory, harm reduction, and self-determination theory: a qualitative exploratory study. Int J Equity Health. 2022;21(1):97.PubMedPubMedCentralCrossRef
38.
Zurück zum Zitat Collins LM, Dziak JJ, Li R. Design of experiments with multiple independent variables: a resource management perspective on complete and reduced factorial designs. Psychol Methods. 2009;14(3):202.PubMedPubMedCentralCrossRef Collins LM, Dziak JJ, Li R. Design of experiments with multiple independent variables: a resource management perspective on complete and reduced factorial designs. Psychol Methods. 2009;14(3):202.PubMedPubMedCentralCrossRef
39.
Zurück zum Zitat Freeman R, Gwadz MV, Silverman E, Kutnick A, Leonard NR, Ritchie AS, et al. Critical race theory as a tool for understanding poor engagement along the HIV care continuum among African American/Black and hispanic persons living with HIV in the United States: a qualitative exploration. Int J Equity Health. 2017;16(1):54.PubMedPubMedCentralCrossRef Freeman R, Gwadz MV, Silverman E, Kutnick A, Leonard NR, Ritchie AS, et al. Critical race theory as a tool for understanding poor engagement along the HIV care continuum among African American/Black and hispanic persons living with HIV in the United States: a qualitative exploration. Int J Equity Health. 2017;16(1):54.PubMedPubMedCentralCrossRef
40.
Zurück zum Zitat Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21(2):271–92.PubMedCrossRef Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21(2):271–92.PubMedCrossRef
42.
Zurück zum Zitat US Department of Veteran Affairs. Measuring Costs for Cost-Effectiveness Analysis. In; 2021. US Department of Veteran Affairs. Measuring Costs for Cost-Effectiveness Analysis. In; 2021.
43.
Zurück zum Zitat Neumann PJ, Sanders GD, Russell LB, Siegel JE, Ganiats TG. Cost-effectiveness in health and medicine. Oxford University Press; 2016. Neumann PJ, Sanders GD, Russell LB, Siegel JE, Ganiats TG. Cost-effectiveness in health and medicine. Oxford University Press; 2016.
44.
Zurück zum Zitat Culyer AJ. Encyclopedia of Health Economics. Elsevier Science; 2014. Culyer AJ. Encyclopedia of Health Economics. Elsevier Science; 2014.
45.
46.
Zurück zum Zitat Ramsey S, Whitley E, Mears VW, McKoy JM, Everhart RM, Caswell RJ, et al. Evaluating the cost-effectiveness of cancer patient navigation programs: conceptual and practical issues. Cancer. 2009;115(23):5394–403.PubMedCrossRef Ramsey S, Whitley E, Mears VW, McKoy JM, Everhart RM, Caswell RJ, et al. Evaluating the cost-effectiveness of cancer patient navigation programs: conceptual and practical issues. Cancer. 2009;115(23):5394–403.PubMedCrossRef
47.
Zurück zum Zitat Rinehart DJ, Stowell M, Collings A, Durfee MJ, Thomas-Gale T, Jones HE, et al. Increasing access to family planning services among women receiving medications for opioid use disorder: a pilot randomized trial examining a peer-led navigation intervention. J Subst Abuse Treat. 2021;126:108318.PubMedPubMedCentralCrossRef Rinehart DJ, Stowell M, Collings A, Durfee MJ, Thomas-Gale T, Jones HE, et al. Increasing access to family planning services among women receiving medications for opioid use disorder: a pilot randomized trial examining a peer-led navigation intervention. J Subst Abuse Treat. 2021;126:108318.PubMedPubMedCentralCrossRef
48.
Zurück zum Zitat Arayasirikul S, Trujillo D, Turner CM, Le V, Wilson EC. Implementing a digital HIV care navigation intervention (health eNav): protocol for a feasibility study. JMIR Res Protocols. 2019;8(11):e16406.CrossRef Arayasirikul S, Trujillo D, Turner CM, Le V, Wilson EC. Implementing a digital HIV care navigation intervention (health eNav): protocol for a feasibility study. JMIR Res Protocols. 2019;8(11):e16406.CrossRef
49.
Zurück zum Zitat Mizuno Y, Higa DH, Leighton CA, Roland KB, Deluca JB, Koenig LJ. Is HIV patient navigation associated with HIV care continuum outcomes? Aids. 2018;32(17):2557–71.PubMedCrossRef Mizuno Y, Higa DH, Leighton CA, Roland KB, Deluca JB, Koenig LJ. Is HIV patient navigation associated with HIV care continuum outcomes? Aids. 2018;32(17):2557–71.PubMedCrossRef
50.
Zurück zum Zitat Allaire BT, Ekweme D, Hoerger TJ, DeGroff A, Rim SH, Subramanian S, et al. Cost-effectiveness of patient navigation for breast cancer screening in the national breast and cervical Cancer Early Detection Program. Cancer Causes Control. 2019;30(9):923–9.PubMedPubMedCentralCrossRef Allaire BT, Ekweme D, Hoerger TJ, DeGroff A, Rim SH, Subramanian S, et al. Cost-effectiveness of patient navigation for breast cancer screening in the national breast and cervical Cancer Early Detection Program. Cancer Causes Control. 2019;30(9):923–9.PubMedPubMedCentralCrossRef
51.
Zurück zum Zitat Bernardo BM, Zhang X, Beverly Hery CM, Meadows RJ, Paskett ED. The efficacy and cost-effectiveness of patient navigation programs across the cancer continuum: a systematic review. Cancer. 2019;125(16):2747–61.PubMedCrossRef Bernardo BM, Zhang X, Beverly Hery CM, Meadows RJ, Paskett ED. The efficacy and cost-effectiveness of patient navigation programs across the cancer continuum: a systematic review. Cancer. 2019;125(16):2747–61.PubMedCrossRef
53.
Zurück zum Zitat Severens JL, Milne RJ. Discounting Health outcomes in economic evaluation: the Ongoing Debate. Value Health. 2004;7(4):397–401.PubMedCrossRef Severens JL, Milne RJ. Discounting Health outcomes in economic evaluation: the Ongoing Debate. Value Health. 2004;7(4):397–401.PubMedCrossRef
54.
Zurück zum Zitat Braithwaite RS, Roberts MS. Are Discount Rates Too High? Population Health and intergenerational equity. Med Decis Mak. 2021;41(2):245–9.CrossRef Braithwaite RS, Roberts MS. Are Discount Rates Too High? Population Health and intergenerational equity. Med Decis Mak. 2021;41(2):245–9.CrossRef
56.
Zurück zum Zitat Fisher L, Tang T, Polonsky W. Assessing quality of life in diabetes: I. A practical guide to selecting the best instruments and using them wisely. Diabetes Res Clin Pract. 2017;126:278–85.PubMedCrossRef Fisher L, Tang T, Polonsky W. Assessing quality of life in diabetes: I. A practical guide to selecting the best instruments and using them wisely. Diabetes Res Clin Pract. 2017;126:278–85.PubMedCrossRef
57.
Zurück zum Zitat Michelson H, Bolund C, Brandberg Y. Multiple chronic health problems are negatively associated with health related quality of life (HRQoL) irrespective of age. Qual Life Res. 2000;9:1093–104.PubMedCrossRef Michelson H, Bolund C, Brandberg Y. Multiple chronic health problems are negatively associated with health related quality of life (HRQoL) irrespective of age. Qual Life Res. 2000;9:1093–104.PubMedCrossRef
58.
Zurück zum Zitat George S, Bergin C, Clarke S, Courtney G, Codd MB. Health-related quality of life and associated factors in people with HIV: an Irish cohort study. Health Qual Life Outcomes. 2016;14(1):115.PubMedPubMedCentralCrossRef George S, Bergin C, Clarke S, Courtney G, Codd MB. Health-related quality of life and associated factors in people with HIV: an Irish cohort study. Health Qual Life Outcomes. 2016;14(1):115.PubMedPubMedCentralCrossRef
59.
Zurück zum Zitat Braithwaite RS, Meltzer DO, King JT Jr, Leslie D, Roberts MS. What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule? Med Care 2008:349–56. Braithwaite RS, Meltzer DO, King JT Jr, Leslie D, Roberts MS. What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule? Med Care 2008:349–56.
60.
Zurück zum Zitat Stead LF, Koilpillai P, Fanshawe TR, Lancaster T. Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane database of systematic reviews 2016; (3). Stead LF, Koilpillai P, Fanshawe TR, Lancaster T. Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane database of systematic reviews 2016; (3).
61.
Zurück zum Zitat Pérez-Bilbao T, Alonso-Dueñas M, Peinado AB, San Juan AF. Effects of Combined interventions of Exercise and Diet or Exercise and supplementation on breast Cancer patients: a systematic review. Nutrients. 2023;15(4):1013.PubMedPubMedCentralCrossRef Pérez-Bilbao T, Alonso-Dueñas M, Peinado AB, San Juan AF. Effects of Combined interventions of Exercise and Diet or Exercise and supplementation on breast Cancer patients: a systematic review. Nutrients. 2023;15(4):1013.PubMedPubMedCentralCrossRef
62.
Zurück zum Zitat Ralaidovy AH, Gopalappa C, Ilbawi A, Pretorius C, Lauer JA. Cost-effective interventions for breast cancer, cervical cancer, and colorectal cancer: new results from WHO-CHOICE. Cost Eff Resource Allocation. 2018;16:1–14. Ralaidovy AH, Gopalappa C, Ilbawi A, Pretorius C, Lauer JA. Cost-effective interventions for breast cancer, cervical cancer, and colorectal cancer: new results from WHO-CHOICE. Cost Eff Resource Allocation. 2018;16:1–14.
63.
Zurück zum Zitat Shepherd E, Gomersall JC, Tieu J, Han S, Crowther CA, Middleton P. Combined diet and exercise interventions for preventing gestational diabetes mellitus. Cochrane Database of Systematic Reviews 2017; (11). Shepherd E, Gomersall JC, Tieu J, Han S, Crowther CA, Middleton P. Combined diet and exercise interventions for preventing gestational diabetes mellitus. Cochrane Database of Systematic Reviews 2017; (11).
64.
Zurück zum Zitat van Duin D, de Winter L, Oud M, Kroon H, Veling W, van Weeghel J. The effect of rehabilitation combined with cognitive remediation on functioning in persons with severe mental illness: systematic review and meta-analysis. Psychol Med. 2019;49(9):1414–25.PubMedCrossRef van Duin D, de Winter L, Oud M, Kroon H, Veling W, van Weeghel J. The effect of rehabilitation combined with cognitive remediation on functioning in persons with severe mental illness: systematic review and meta-analysis. Psychol Med. 2019;49(9):1414–25.PubMedCrossRef
65.
Zurück zum Zitat Grossbard JR, Mastroleo NR, Kilmer JR, Lee CM, Turrisi R, Larimer ME, et al. Substance use patterns among first-year college students: secondary effects of a combined alcohol intervention. J Subst Abuse Treat. 2010;39(4):384–90.PubMedPubMedCentralCrossRef Grossbard JR, Mastroleo NR, Kilmer JR, Lee CM, Turrisi R, Larimer ME, et al. Substance use patterns among first-year college students: secondary effects of a combined alcohol intervention. J Subst Abuse Treat. 2010;39(4):384–90.PubMedPubMedCentralCrossRef
66.
Zurück zum Zitat Teesson M, Newton NC, Slade T, Chapman C, Birrell L, Mewton L, et al. Combined prevention for substance use, depression, and anxiety in adolescence: a cluster-randomised controlled trial of a digital online intervention. Lancet Digit Health. 2020;2(2):e74–84.PubMedCrossRef Teesson M, Newton NC, Slade T, Chapman C, Birrell L, Mewton L, et al. Combined prevention for substance use, depression, and anxiety in adolescence: a cluster-randomised controlled trial of a digital online intervention. Lancet Digit Health. 2020;2(2):e74–84.PubMedCrossRef
67.
Zurück zum Zitat Collins LM, Dziak JJ, Kugler KC, Trail JB. Factorial experiments: efficient tools for evaluation of intervention components. Am J Prev Med. 2014;47(4):498–504.PubMedPubMedCentralCrossRef Collins LM, Dziak JJ, Kugler KC, Trail JB. Factorial experiments: efficient tools for evaluation of intervention components. Am J Prev Med. 2014;47(4):498–504.PubMedPubMedCentralCrossRef
68.
Zurück zum Zitat Spring B, Pfammatter AF, Marchese SH, Stump T, Pellegrini C, McFadden HG, et al. A factorial experiment to optimize remotely delivered behavioral treatment for obesity: results of the Opt-IN study. Obesity. 2020;28(9):1652–62.PubMedCrossRef Spring B, Pfammatter AF, Marchese SH, Stump T, Pellegrini C, McFadden HG, et al. A factorial experiment to optimize remotely delivered behavioral treatment for obesity: results of the Opt-IN study. Obesity. 2020;28(9):1652–62.PubMedCrossRef
70.
Zurück zum Zitat Strayhorn JC, BDJ, Gwadz M, Cleland CM, Collins LM. Using decision analysis for intervention value efficiency (DAIVE) to select optimized HIV care continuum interventions in the multiphase optimization strategy (MOST). Health Psychol 2023; in press. Strayhorn JC, BDJ, Gwadz M, Cleland CM, Collins LM. Using decision analysis for intervention value efficiency (DAIVE) to select optimized HIV care continuum interventions in the multiphase optimization strategy (MOST). Health Psychol 2023; in press.
Metadaten
Titel
Empirical Development of a Behavioral Intervention for African American/Black and Latino Persons with Unsuppressed HIV Viral Load Levels: An Application of the Multiphase Optimization Strategy (MOST) Using Cost-Effectiveness as an Optimization Objective
verfasst von
Jonathan Feelemyer
R Scott Braithwaite
Qinlian Zhou
Charles M. Cleland
Prima Manandhar-Sasaki
Leo Wilton
Amanda Ritchie
Linda M. Collins
Marya V. Gwadz
Publikationsdatum
25.04.2024
Verlag
Springer US
Erschienen in
AIDS and Behavior
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-024-04335-w

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.